Definitive Healthcare Corp. (NASDAQ:DH) Q3 2022 Results Conference Call November 3, 2022 5:00 PM ET
Company Participants
David Samuels - Chief Legal Officer
Robert Musslewhite - CEO
Jason Krantz - Founder & Chairman
Rick Booth - CFO
Conference Call Participants
Craig Hettenbach - Morgan Stanley
Joe Vruwink - Baird
Saket Kalia - Barclays
David Grossman - Stifel
Maxi Ma - Deutsche Bank
Jonathan Yong - Credit Suisse
Matt Shea - Needham
Johnathan McCary - Raymond James
Operator
Good morning, afternoon, evening, and welcome to the Definitive Healthcare's Third Quarter 2022 Earnings Call. All participants will be in a listen-only mode. [Operator Instructions] After today's presentation, there will be an opportunity to ask question. [Operator Instructions] Please note that this event is being recorded.
I would now like to turn the conference over to David Samuels, Chief Legal Officer. Please go ahead.
David Samuels
Good afternoon and thank you for joining us today to review Definitive Healthcare's Third Quarter 2022 financial results. Joining me on the call today are Robert Musslewhite, CEO; Jason Krantz, Founder and Executive Chairman; and Rick Booth, CFO.
During this call, we will make forward-looking statements, including, but not limited to, statements related to our market and future performance and growth opportunities, the benefits of our healthcare commercial intelligence solutions, our competitive position, customer behaviors, our financial guidance, our planned investments and the anticipated impacts of the COVID-19 pandemic and global macroeconomic conditions on our business results and clients and on the health care industry generally.
Any looking forward statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve a number of risks and uncertainties, including those discussed in the Risk Factors section and elsewhere in our filings with the SEC.
Actual results may differ materially from any forward-looking statements. The company undertakes no obligation to revise or update any forward-looking statements to reflect events that may arise after this conference call, except as required by law. For more information, please refer to the cautionary statements included in the earnings release that we have just posted to the Investor Relations portion of our website.
Additionally, we will discuss non-GAAP financial measures on this conference call. Please refer to the tables in our earnings release on the Investor Relations portion of our website for a reconciliation of these measures to their most directly comparable GAAP financial measure.